D-0626-2024Class I

MAIN PRODUCTS INC

Recalling firm

MAIN PRODUCTS INC

Product type

Drug

Status

Ongoing

Report date

2024-08-14

Distribution

Nationwide within the U.S

Firm state

Product quantity

57, 340 bottles

Initiated by

Voluntary: Firm initiated

SPEQ quality domain

Documentation & Change Control

Reason for recall

Marketed without Approved NDA/ANDA. FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

Product description

Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

Code / lot info

All lots within expiry

Other recalls SPEQ maps to Documentation & Change Control

2026-07-22Class IIDaavlin Distributing Company 2026-07-22Class ID'Dioses Fruit Pops, Inc.2026-07-22Class ID'Dioses Fruit Pops, Inc.2026-07-22Class IIChocolate Bar Holdings LLC

See all Documentation & Change Control recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.